- Investing Ideas
- Global Pharmaceuticals & Biotech Low-Risk Leaders
Global Pharmaceuticals & Biotech Low-Risk Leaders
Results
16
16 companies
Camurus
Market Cap: SEK 34.5b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 578.00
7D
2.2%
1Y
-13.9%
Inner Mongolia Furui Medical Science
Market Cap: CN¥11.2b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥42.46
7D
9.2%
1Y
31.5%
Granules India
Market Cap: ₹213.9b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.
532482
₹863.35
7D
6.2%
1Y
79.2%
Neurocrine Biosciences
Market Cap: US$17.5b
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
NBIX
US$177.49
7D
5.3%
1Y
37.9%
ALK-Abelló
Market Cap: DKK 53.5b
An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.
ALK B
DKK 241.60
7D
-1.1%
1Y
26.7%
Shilpa Medicare
Market Cap: ₹117.4b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.
530549
₹600.10
7D
0.3%
1Y
39.4%
UCB
Market Cap: €48.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€253.80
7D
-3.1%
1Y
49.2%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥55.0b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥122.19
7D
11.9%
1Y
32.4%
United Therapeutics
Market Cap: US$23.2b
Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR
US$563.70
7D
4.0%
1Y
91.5%
Catalyst Pharmaceuticals
Market Cap: US$3.9b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$31.49
7D
0.2%
1Y
51.8%
ST PharmLtd
Market Cap: ₩2.7t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩128,700.00
7D
-2.6%
1Y
53.8%
Caplin Point Laboratories
Market Cap: ₹195.1b
Engages in the development, production, marketing, and export of generic formulations and branded products in India.
524742
₹2,566.10
7D
-2.2%
1Y
27.0%
Otsuka Holdings
Market Cap: JP¥6.0t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥11,515.00
7D
6.6%
1Y
73.9%
Hanmi Pharm
Market Cap: ₩5.5t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩430,000.00
7D
8.2%
1Y
52.5%
Veracyte
Market Cap: US$4.6b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$58.00
7D
-3.6%
1Y
120.2%
HARBIN GLORIA PHARMACEUTICALS
Market Cap: CN¥6.7b
Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
002437
CN¥3.00
7D
11.1%
1Y
2.7%